<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Reimer JM</submitter><funding>NIGMS NIH HHS</funding><pagination>1735-1745</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10643122</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>30(11)</volume><pubmed_abstract>Leucine Rich Repeat Kinase 1 and 2 (LRRK1 and LRRK2) are homologs in the ROCO family of proteins in humans. Despite their shared domain architecture and involvement in intracellular trafficking, their disease associations are strikingly different: LRRK2 is involved in familial Parkinson's disease while LRRK1 is linked to bone diseases. Furthermore, Parkinson's disease-linked mutations in LRRK2 are typically autosomal dominant gain-of-function while those in LRRK1 are autosomal recessive loss-of-function. Here, to understand these differences, we solved cryo-EM structures of LRRK1 in its monomeric and dimeric forms. Both differ from the corresponding LRRK2 structures. Unlike LRRK2, which is sterically autoinhibited as a monomer, LRRK1 is sterically autoinhibited in a dimer-dependent manner.</pubmed_abstract><journal>Nature structural &amp; molecular biology</journal><pubmed_title>Structure of LRRK1 and mechanisms of autoinhibition and activation.</pubmed_title><pmcid>PMC10643122</pmcid><funding_grant_id>R35 GM133633</funding_grant_id><pubmed_authors>Knapp S</pubmed_authors><pubmed_authors>Dickey AM</pubmed_authors><pubmed_authors>Lin YX</pubmed_authors><pubmed_authors>Mathea S</pubmed_authors><pubmed_authors>Leschziner AE</pubmed_authors><pubmed_authors>Fay EJ</pubmed_authors><pubmed_authors>Reck-Peterson SL</pubmed_authors><pubmed_authors>Abrisch RG</pubmed_authors><pubmed_authors>Reimer JM</pubmed_authors><pubmed_authors>Chatterjee D</pubmed_authors><pubmed_authors>Daugherty MD</pubmed_authors></additional><is_claimable>false</is_claimable><name>Structure of LRRK1 and mechanisms of autoinhibition and activation.</name><description>Leucine Rich Repeat Kinase 1 and 2 (LRRK1 and LRRK2) are homologs in the ROCO family of proteins in humans. Despite their shared domain architecture and involvement in intracellular trafficking, their disease associations are strikingly different: LRRK2 is involved in familial Parkinson's disease while LRRK1 is linked to bone diseases. Furthermore, Parkinson's disease-linked mutations in LRRK2 are typically autosomal dominant gain-of-function while those in LRRK1 are autosomal recessive loss-of-function. Here, to understand these differences, we solved cryo-EM structures of LRRK1 in its monomeric and dimeric forms. Both differ from the corresponding LRRK2 structures. Unlike LRRK2, which is sterically autoinhibited as a monomer, LRRK1 is sterically autoinhibited in a dimer-dependent manner.</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Nov</publication><modification>2026-07-14T19:18:00.817Z</modification><creation>2025-04-04T07:24:26.449Z</creation></dates><accession>S-EPMC10643122</accession><cross_references><pubmed>37857821</pubmed><doi>10.1038/s41594-023-01109-1</doi></cross_references></HashMap>